Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Fagron SA ( (GB:0HNZ) ) has provided an update.
Fagron has announced strategic acquisitions of CareFirst Specialty Pharmacy in North America and Injeplast in Brazil, with a combined value of approximately €30 million. These acquisitions are in line with Fagron’s strategy to expand in key markets and are expected to enhance its market presence in both the North American and Latin American regions. CareFirst will bolster Fagron’s reach in the North American prevention and lifestyle markets, while Injeplast will support its Essentials strategy by expanding the product portfolio and customer base in Latin America, ultimately strengthening Fagron’s global operations.
More about Fagron SA
Fagron is a globally recognized leader in pharmaceutical preparations, offering personalized pharmaceutical care solutions to hospitals, pharmacies, clinics, and patients across over 30 countries. Fagron NV is based in Nazareth, Belgium, and trades on Euronext Brussels and Amsterdam. Its operational activities are managed by Fagron BV, headquartered in Rotterdam, Netherlands.
YTD Price Performance: -0.02%
Average Trading Volume: 8,068
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €1.21B
Find detailed analytics on 0HNZ stock on TipRanks’ Stock Analysis page.